Elanco has struck an agreement to distribute a vaccine that may protect cattle for up to 12 months against bird flu ...

GREENFIELD, IN / ACCESS Newswire / February 25, 2025 / Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has ...

Zoetis also has an H5N1 vaccine, for which it received a conditional license in 2016 and a contract award for the USDA’s ...

Elanco (ELAN) has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.

GREENFIELD, IN / ACCESS Newswire / February 25, 2025 / Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage ...

Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...

GREENFIELD, Ind., Feb. 25, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage the ...

Elanco Animal Health (NYSE:ELAN) Incorporated (NYSE: ELAN), a $5.5 billion market cap company with annual revenues of $4.45 billion, has announced a partnership with Medgene Labs to commercialize ...

(RTTNews) - Elanco Animal Health Incorporated (ELAN) Tuesday announced a partnership with South Dakota-based Medgene to commercialize a vaccine for highly pathogenic avian influenza in dairy cattle.

Elanco Animal Health (NYSE:ELAN) stock falls as the company reports mixed Q4 2024 results, and sets 2025 outlook below consensus due to forex headwinds. Read more here.